Lymphoscintigraphy in Lymphedema: Procedure and Interpretation Guideline by the Korean Society of Nuclear Medicine and Korean Society of Lymphedema Part II
Clinical Lymphology and Lymphedema · 2025-05 · 10 (1) · 1-13
DOI: 10.67326/cll.2025.10.1.1 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Lymphology and Lymphedema, online erschienen am 17.05.2025. Verfasst von Minseok Suh und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Lymphoscintigraphy is a non-invasive nuclear medicine imaging technique widely utilized in diagnosing and assessing lymphedema by visualizing lymphatic function after subcutaneous injection of radiopharmaceuticals. Accurate interpretation of lymphoscintigraphy is essential, as it directly impacts clinical decision-making, patient prognosis prediction, and assessment of therapeutic response. However, variability in interpretation criteria and quantitative assessments among institutions has led to inconsistency in clinical application and challenges in treatment planning. To address these issues, the Korean Society of Nuclear Medicine and the Korean Society of Lymphedema have collaboratively developed a procedure and interpretation guideline, reflecting current clinical practices and the availability of 99mTc-phytate in the Republic of Korea. This guideline specifically focuses on the standardized qualitative and quantitative criteria for lymphoscintigraphic interpretation, outlines normal and abnormal imaging findings, and discusses interpretation standards according to clinical indication followed by previous Part I. Adoption of this guideline aims to improve the consistency of interpretations, facilitate more effective clinical management strategies, and ultimately enhance the quality of care provided to patients with lymphedema.
Zitieren
APA
Suh, M., Han, S., Yoo, M. Y., Chae, S. Y., & Choi, J. Y. (2025). Lymphoscintigraphy in Lymphedema: Procedure and Interpretation Guideline by the Korean Society of Nuclear Medicine and Korean Society of Lymphedema Part II. Clinical Lymphology and Lymphedema, 10(1), 1-13. https://doi.org/10.67326/cll.2025.10.1.1
Vancouver
Suh M, Han S, Yoo MY, Chae SY, Choi JY. Lymphoscintigraphy in Lymphedema: Procedure and Interpretation Guideline by the Korean Society of Nuclear Medicine and Korean Society of Lymphedema Part II. Clinical Lymphology and Lymphedema. 2025;10(1):1-13. doi:10.67326/cll.2025.10.1.1
BibTeX
@article{Suh2025,
author = {Suh, Minseok and Han, Sangwon and Yoo, Min Young and Chae, Sun Young and Choi, Joon Young},
title = {Lymphoscintigraphy in Lymphedema: Procedure and Interpretation Guideline by the Korean Society of Nuclear Medicine and Korean Society of Lymphedema Part II},
journal = {Clinical Lymphology and Lymphedema},
year = {2025},
volume = {10},
number = {1},
pages = {1--13},
doi = {10.67326/cll.2025.10.1.1}
}
EUVIMED